TRAVERE THERAPEUTICS INC (TVTX) Stock Cash Flow
NASDAQ:TVTX - Nasdaq - US89422G1076 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -169.06M | -321.55M | -111.40M | -278.48M | -180.09M | |||
| Depreciation Amortization | 50.15M | 43.55M | 38.53M | 33.08M | 26.62M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -28.67M | -63.02M | -25.48M | 900.00K | 79.98M | |||
| Interest Paid | N/A | 8.84M | 8.84M | 10.16M | 7.33M | |||
| Taxes Paid | N/A | 453.00K | 578.00K | 1.00M | -16.42M | |||
| Other non cash items | 32.14M | 103.53M | -181.68M | 58.21M | 58.70M | |||
| OPERATING CASH FLOW | -115.44M | -237.47M | -280.02M | -186.29M | -14.79M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -41.86M | -101.21M | -42.26M | -28.56M | -24.15M | |||
| Other Investing Activity | 53.81M | 200.54M | 98.03M | -4.00M | -113.47M | |||
| INVESTING CASH FLOW | 11.96M | 99.33M | 55.78M | -32.55M | -137.62M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 0.00 | 104.93M | N/A | |||
| Stock Issued/Repurchased | 143.90M | 139.19M | 219.07M | 24.13M | 237.78M | |||
| Other Financing Activity | 462.00K | 232.00K | -316.00K | -11.48M | -6.09M | |||
| FINANCING CASH FLOW | 144.36M | 139.42M | 218.75M | 117.57M | 231.68M | |||
| Exchange Rate Effect | 1.99M | -913.00K | 1.98M | -2.79M | 1.71M | |||
| CHANGE IN CASH | 42.86M | 359.00K | -3.51M | -104.06M | 80.98M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -115.44M | -237.47M | -280.02M | -186.29M | -14.79M | |||
| Capital Expenditure | -41.86M | -101.21M | -42.26M | -28.56M | -24.15M | |||
| FREE CASH FLOW | -157.30M | -338.69M | -322.28M | -214.85M | -38.94M | |||
All data in USD